Event
RSC-BMCS 3rd Conformational Design in Drug Discovery 2026
Date: 2 March 2026
Location: Stevenage, UK
Katie Headland, Senior Director
Business Development UK
Axxam at Conformational Design in Drug Discovery 2026
Axxam will attend Conformational Design in Drug Discovery 2026, the scientific meeting organized by the RSC-BMCS (Royal Society of Chemistry – Biological and Medicinal Chemistry Sector) dedicated to the latest advances in medicinal chemistry and drug discovery.
The conference brings together researchers from academia, biotechnology companies, and pharmaceutical organizations to explore strategies for conformational design, structure-based drug discovery, and the optimization of small molecules with improved selectivity and efficacy.
Advancing Molecular Design in Drug Discovery
Understanding and controlling molecular conformation is a key aspect of modern drug discovery programs. By shaping how molecules interact with biological targets, conformational design can influence potency, selectivity, and pharmacological properties.
The meeting will highlight recent developments in medicinal chemistry, computational modeling, and structural biology, offering insights into innovative approaches used to design and optimize next-generation therapeutics.
Meet Axxam at the RSC-BMCS Conference
Katie Headland, our BD Senior Director , will attend the event and will be available to connect with scientists and industry professionals interested in discussing new opportunities in drug discovery research.
With more than two decades of experience in integrated discovery services, Axxam supports pharmaceutical and biotech partners through advanced platforms for assay development, screening, and compound profiling.
Supporting Drug Discovery Programs
Axxam’s multidisciplinary teams combine expertise in biochemistry, cellular pharmacology, electrophysiology, and high-throughput screening to accelerate early-stage drug discovery.
Through tailored assay development and screening solutions, we help partners identify and characterize novel compounds across a wide range of therapeutic areas.
If you are attending Conformational Design in Drug Discovery 2026 and would like to learn more about Axxam’s capabilities or discuss potential collaborations, we would be pleased to connect during the meeting.